New scan aims to predict ovarian Cancer's aggressiveness
NCT ID NCT05866679
Summary
This study aims to test a new type of MRI scan that uses a special contrast agent to see if it can measure how aggressive an ovarian cancer might be before surgery. It will involve 30 participants, including people at high risk for ovarian cancer and those already suspected of having it. The main goal is to see if the scan is safe and can detect specific chemical changes in the tumor.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.